We offer a full range of intellectual property and business valuation services in the context of IP transactions, licensing, M&A, spinoffs and fundraising across a wide range of industries and technologies.
Over the past decade, the Foresight Team has advised sophisticated technology companies on the valuation and monetization of their IP assets. Foresight has conducted hundreds of valuation engagements for some of the leading IP holders around the world.
|From the definition of the scope, to the delivery of the final report, Foresight consistently provided outstanding services on a timely basis that culminated in a highly valuable robust asset. There is no hesitation in our assessment that you have added immense value to our stockholders which should equally serve well as a set of lenses to our future investors.
Penelope Salmons, President, Fibrtec
- Trade Secrets
- Digital Assets
- Mergers & Acquisitions
- Patent Sales/Purchases
- Licensing/Cross-Licensing Agreements
- In-Kind Contributions
- Joint Ventures
- Technology Spin-Offs
- Market Assessments
- IP Valuation for Funding
- Fair Value for Financial Reporting
- Transfer Pricing
- Royalty Studies
|They did an excellent job with our token valuation report. They were able to pick up new/complicated concepts very quickly, were super responsive and sensitive to our tight timelines, and overall produced a high-quality valuation report. We’d recommend their services to anyone working in the crypto/protocol/utility tokens area.Co-Founder, Blockchain Startup|
Valuation Analysis Case Studies
Patent Portfolio Valuation, Memory Technology, Global Consumer Electronics Company
Valuation of a large patent portfolio (including Standard Essential patents as well as Non-Standard patents) related to Dynamic Random Access Memory Technology for a publicly traded global consumer electronics company. The valuation was done for the Board of Directors’ approval of the cost of entering into a joint venture with the 3rd party holder of the patent portfolio.
Patent Valuation and Monetization Strategy, Audio/Video Streaming Company
Valuation of a portfolio of seminal video technology patents and applications, under various monetization scenarios and business models, to inform our Client of the best strategy to monetize the IP portfolio. Our recommendations were implemented by our Client, a public US company, and resulted in the sale of the IP portfolio to a group of international buyers for a total purchase price of between $40 million and $80 million.
Valuation of Access Token, Decentralized Internet/Blockchain Startup
Valuation of access control Token developed by a venture-backed leading blockchain startup, to be used in an ecosystem of decentralized internet applications. The analysis included the pre-launch valuation of the Token for use in the pricing of commodity option purchase agreements, as well as the post-launch valuation of the same Token, following our Client’s $50M Token presale funding event.
Brand and Business Valuation, Global Consumer Electronics Company
Fair Market Value assessment of the brand and equity of an international consumer electronics company, ranked as one of the Top 5 leading brands in the Middle East & Africa. The analysis included the re-working of the company’s financial projections and special care in understanding the unique funding history of the company. Specific consideration was given to the company’s brand, as it was identified as the main value-driving asset.
Virtual Reality Game Title Valuation for Spinoff, Japanese Game Developer
Valuation of game titles for a Japanese game developer. Parent company was seeking to transfer certain game titles, including virtual reality and mobile titles, to a US entity, and the valuation analysis was performed for tax reporting purposes. The valuation included the creation of user cohort projections, specifically considering the game lifecycle.
Patent Portfolio Valuation, Molecular Diagnostic Technology, BioTech Company
Valuation of a portfolio of patents and applications related to molecular diagnostics for thyroid cancer and solid tumors. The valuation was done for the Private Equity holding company that sought the Fair Market Value of the assets for use as collateral for debt financing purposes.